Vernon Hills, IL, United States of America

Kirill A Lukin

USPTO Granted Patents = 19 (Patent Applications = 3)

CIPO Patents = 5 (Patent Applications = 5)

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 4.6

ph-index = 5

Forward Citations = 73(Granted Patents)

Location History:

Mundelein, IL (US) (2001 - 2012)
Vernon Hills, IL (US) (2008 - 2019)

Company Filing History:

9 out of 4,177

Abbott Laboratories Corporation

Years Active: 2001-2019

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10442792 - Synthetic route to anti-viral agents (2019-10-15),

2. 10421712 - Difluoroalkylcyclopropyl amino acids and esters, and syntheses thereof (2019-09-24),

3. 10077256 - Synthetic route to anti-viral agents (2018-09-18),

4. 9809576 - Synthetic route to anti-viral agents (2017-11-07),

5. 9809534 - Difluoroalkylcyclopropyl amino acids and esters, and syntheses thereof (2017-11-07),

6. 9346785 - Process for making HCV protease inhibitors (2016-05-24),

7. 8519186 - Process for the preparation of indazolyl ureas that inhibit Vanilloid subtype 1 (VR1) receptors (2013-08-27),

8. 8487116 - Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor (2013-07-16),

9. 8273767 - Bicyclic-substituted amines as histamine-3 receptor ligands (2012-09-25),

10. 8232411 - Methods for making central nervous system agents that are TRPV1 antagonists (2012-07-31),

11. 8071762 - Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor (2011-12-06),

12. 7956195 - Process for the preparation and isolation of the individual stereoisomers of 1-amino, 3-substituted phenylcyclopentane-carboxylates (2011-06-07),

13. 7847104 - Process for the preparation of indazolyl ureas that inhibit Vanilloid subtype1 (VR1) receptors (2010-12-07),

14. 7375126 - Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor (2008-05-20),

15. 7189849 - Synthesis of acyclic nucleoside derivatives (2007-03-13),

Title: The Innovative Contributions of Kirill A. Lukin

Introduction: Kirill A. Lukin, a prominent inventor based in Vernon Hills, IL, holds an impressive portfolio of 19 patents. His work primarily focuses on the development of novel anti-viral agents and compounds that demonstrate significant potential in pharmaceutical applications.

Latest Patents: Among his recent innovations are two noteworthy patents. The first, titled "Synthetic route to anti-viral agents," outlines methods for synthesizing a viral protease inhibitor in high yield, utilizing cost-effective methods that avoid expensive catalysts and complicated reaction conditions. The second, "Difluoroalkylcyclopropyl amino acids and esters, and syntheses thereof," details techniques for synthesizing compounds in an asymmetric or enantioenriched manner. These compounds serve as useful intermediates in producing viral protease inhibitors, showcasing significant advancements in the field of medicinal chemistry.

Career Highlights: Kirill has made substantial contributions while working for notable companies in the pharmaceutical industry, including Abbott Laboratories Corporation and AbbVie Inc. His experience in these organizations has enabled him to leverage his expertise and creativity in developing innovative solutions for pressing health issues.

Collaborations: Throughout his career, Kirill A. Lukin has collaborated with talented individuals such as Marvin Robert Leanna and Russell Drew Cink. These partnerships have fostered an environment of innovation and have been instrumental in driving forward the research and development of vital pharmaceutical interventions.

Conclusion: Kirill A. Lukin's dedication to innovation is evident in his extensive patent portfolio and his work alongside prominent companies and collaborators. His contributions to the field of medicinal chemistry hold promise for advancing the development of effective anti-viral agents, making a significant impact on public health.

This text is generated by artificial intelligence and may not be accurate.